Trademark Overview
On Friday, November 21, 2025, a trademark application was filed for DROMATRIX with the United States Patent and Trademark Office. The USPTO has given the DROMATRIX trademark a serial number of 99509555. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 21, 2025. This trademark is owned by Pike Therapeutics USA, Inc.. The DROMATRIX trademark is filed in the Pharmaceutical Products category with the following description:
Transdermal patches featuring dronabinol for pain relief, to treat loss of appetite, severe nausea and vomiting caused by chemotherapy, to treat neuropsychiatric disorders, namely anxiety disorders, depression disorders, sleep disorders, autism spectrum disorders, seizure disorders, cognitive deficit disorders, and Tourette syndrome (TS), and to treat neurological diseases, namely, Alzheimer's disease, dementia, Parkinson's disease, Chronic traumatic encephalopathy (CTE), Multiple sclerosis (MS), epilepsy, peripheral neuropathy, migraine, and strokes
